Alternatives
Alternatives to Naropin 150 mg/30 mL injection
2 other presentations of Ropivacaine 150 mg/30 mL injection
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Ropivacaine), strength (150 mg/30 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Naropin 150 mg/30 mL injectionThis pageEpidural, infiltration, perineural | Fresenius Kabi | US FDA | 1 vial of 30 mL, 5 vials of 30 mL | Solutions should be stored at 20ºC to 25°C (68ºF to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). | On request | — | Available on request |
| Ropivacaine 150 mg/30 mL injectionEpidural, infiltration, perineural | — | US FDA | 5 vials of 30 mL, 25 vials of 30 mL | Solutions should be stored at 20 °C to 25 °C (68 °F to 77 °F). | On request | — | Available on request |
| Ropivacaine 150 mg/30 mL injectionEpidural, infiltration | — | US FDA | 10 vials of 30 mL | Solutions should be stored at 20º to 25°C (68º to 77°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Naropin 150 mg/30 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.